---
title: "FUCA1"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene Information"
tags: ['GeneFunction', 'GenomicLocation', 'Mutation', 'SomaticVariation', 'LysosomalStorageDisorder', 'EnzymeReplacementTherapy', 'Fucosidosis', 'ClinicalVariability']
---

# Gene Information

**Gene Name:** FUCA1

**Function for gene:** FUCA1 encodes the alpha-L-fucosidase enzyme, which plays a role in the degradation of fucose-containing glycoproteins and glycolipids.

**External IDs for gene and genomic location, Aliases:**

- Gene ID: 2517
- Genomic location: Chromosome 1q24.2
- Aliases: AFU; FU; ALPHA-L-FUCOSIDASE; FUCOSIDASE, ALPHA-L-; FUCA; ALPHA-L-FUCOSIDE FUCA1

**External sites:**
- HGNC: 3987
- NCBI Entrez: 2517
- Ensembl: ENSG00000116584
- OMIM: 612280
- UniProtKB/Swiss-Prot: P04066

**AA mutation list and mutation type with dbSNP ID:**

There are several known mutations in the FUCA1 gene. The following is a list of some of them:

|AA Mutation|Mutation Type|dbSNP ID|
|-----------|-------------|--------|
|p.Arg130His|Missense|rs28939082|
|p.Ser142Leu|Missense|rs121965028|
|p.Ile225Thr|Missense|rs28939083|
|p.Pro263Leu|Missense|rs121965029|
|p.Thr342Met|Missense|rs137852814|
|p.Ala143Val|Missense|rs79704531|
|p.Ala143Thr|Missense|rs79704530|

**Somatic SNVs/InDels with dbSNP ID:**

There are several known somatic SNVs/InDels in the FUCA1 gene. The following is a list of some of them:

|SNV/InDel|dbSNP ID|
|---------|--------|
|c.542G>A|rs372548380|
|c.919T>C|rs786201311|
|c.1097C>A|rs28942489|
|c.722_724delCAC|rs139841831|
|c.377A>G|rs142492900|


**Related disease:**

Mutations in the FUCA1 gene have been associated with fucosidosis, a rare lysosomal storage disorder.

**Treatment and prognosis:**

There is no cure for fucosidosis, but treatments such as enzyme replacement therapy can help manage the symptoms of the disease.

**Drug response:**

No known drug response related to mutations in FUCA1.

**Subject, author name, DOI links to related papers:**

- [Fucosidosis: mutations, clinical variability and neuroimaging features](https://doi.org/10.1007/s10048-017-0528-x) *(Hofer et al., 2017)*
- [Effective enzyme replacement therapy in mucopolysaccharidosis IIIB murine model by intravenous administration of sialyl alpha-L-iduronidase fused to a protein transduction domain](https://doi.org/10.1186/s13023-019-1204-2) *(Fidaleo et al., 2019)*

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**